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Introduction: The cancer stem cell model links neoplastic cells with normal stem cell biology, but little is known
on how normal stem cells are transformed into cancer stem cells.
Methods: To investigate the processes underlying the transformation of normal stem cells we developed in vitro a
cancer stem cell model from human amniotic and chorionic placenta membranes. In this model we studied
the expression of specific stem cell molecules by flow cytometry, and genes, by real time RT-PCR. Microscopy
immunfluorescence was employed to investigate the proliferative and differentiation patterns. Fluorescence
microscopy and FACS were employed to investigate the proliferative and differentiation patterns. To evaluate the
tumorigenic potential of our model we injected the cells into NOD.CB17-Prkdcscid/NCrHsd mice.
Results: Normal human stem cells from amniotic and chorionic placenta membranes were converted into neural
cell lineages, under specific conditions, to form secondary neurospheres with a capacity for self-renewal. After
extensive in vitro culture, these cells underwent spontaneous transformations and acquired a neuroblastoma
(NB)-like phenotype with an elevated proliferative potential that is comparable to established neuroblastoma cell
lines. The ability of these cells to transform their phenotype was evidenced by increased clonogenic ability in vitro;
by augmented expression level of certain proliferation- and transformation-related genes (e.g., CCNA2, MYCN,
ENPP2, GRIA3, and KIT); by the presence of multinucleated and hyperdiploid cells. We further demonstrated that the
transformed phenotype is an NB by measuring the expression of NB-specific markers, disialoganglioside GD2 and
N-Myc proteins.
Conclusions: We have developed a cancer stem cell model starting from normal human stem cells derived from
amniotic and chorionic placenta membranes. These cells are able to differentiate into neural cell lineages and to
undergo spontaneous transformations and acquire an NB-like phenotype.Introduction
Neuroblastoma (NB) is a very aggressive solid tumour
and is the most commonly diagnosed solid tumour in
children [1,2]. Although NB disease remission can fre-
quently be achieved for patients via a combination of
surgery, radiation and chemotherapy, relapse is very com-
mon. Recent studies demonstrate that NB is generated* Correspondence: bucci.barbara@fbfrm.it
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distribution, and reproduction in any mediumand maintained by a small cell population of undifferenti-
ated cells (1% to 2% of the total), which are identified as
the tumour-initiating cells (TICs) and are commonly de-
fined as cancer stem cells (CSCs). These cells play an im-
portant role in carcinogenesis and tumour progression [3].
There is increasing evidence confirming the presence
of CSCs in other solid tumours, including breast, brain,
prostate, colon and lung cancers, as well as haemato-
poietic tumours, such as leukaemia [4-9]. These cells are
characterised by extensive potential for self-renewal (serial
sphere formation) driving tumourigenesis [10]. They showtral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited.
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(CD133), a surface marker of normal stem cells [3,11,12].
Tumour tissue-derived CSCs are usually used as a model
to study the biological properties of CSCs in solid tumours
[3,13,14]. However, because CSCs represent a very small
subset of tumour cells, the molecular mechanisms in-
volved in expansion and neoplastic transformations have
yet to be elucidated. Therefore, more insight into the mo-
lecular mechanisms that predispose normal stem cells to
undergo malignant transformations is needed and may
help develop selective therapeutic strategies to target
CSCs. To study the formation of CSCs, different models
derived from normal adult or embryonic tissues, which
were spontaneously or forcedly transformed, have been
developed. Gro Vatne Røsland and colleagues charac-
terised a model of human adult mesenchymal stem cells
(MSCs) derived from normal [15] bone marrow that
undergo spontaneous malignant transformation following
in vitro culture.
Milyavsky and collaborators [16] reported that a pro-
longed culture of telomerase-immortalised human fi-
broblasts also acquired a pre-malignant phenotype. In
addition, Okamoto and colleagues [17] provided a gen-
omic characterisation of CD133-positive stem cells de-
rived from umbilical cord blood and stimulated the cells
to proliferate (in vitro expansion) with estradiol; in this
study, they identified genes and signalling pathways in-
volved in both stem cell expansion and haematological
cancer development [17]. Although the use of embryonic
tissues after long-term culture expansion appears to be
advantageous in terms of expansion potential and sus-
ceptibility to malignant transformation compared with
adult tissues, ethical issues limit the use of these tissues.
In this paper, we demonstrate that human placental
foetal tissues (amnion and chorion membranes) maintai-
ning most of the embryonic properties could represent a
physiologic pluripotent model of MSCs not obtained by
forced genetic reprogramming of somatic cells. We also
converted MSCs into neural lineages by spheres forming
under specific conditions, and after extensive culture
in vitro adherent placenta-derived (PD) neurospheres
undergo spontaneous transformations and acquire an
NB-like phenotype. It is noteworthy that placental tis-
sues are normally discarded after birth, abundantly avail-
able and ethically unobjectionable, thus overcoming the
ethical concerns related to the use of umbilical cord
blood [2].Methods
Ethics statement
The study was approved by the Ethics Committee of San
Pietro Hospital Fatebenefratelli (64/2012/cb) and all par-
ticipants gave written, informed consent.The procedures involving mice and their care were in
compliance with Regina Elena National Cancer Institute
animal care guidelines and with international directives
(directive 2010/63/EU of the European parliament and
of the council; Guide for the Care and Use of Labora-
tory Animals, United States National Research Council,
2011).
Isolation and culture of MSCs from human placentas
The human term placentas were collected from a cohort
of 35 women at gestational weeks 39 ± 1. Mean maternal
age was 30 years. Following informed consent, placentas
were collected immediately after elective caesarean sec-
tion in the absence of labour, preterm rupture of mem-
brane, chorioamnionitis or chromosomal abnormalities.
From each placenta, we collected the foetal membranes
(amnion and chorion) and washed them in physiolo-
gic saline solution. We proceeded to do a mechanical
digestion and then, the tissue was subjected to three se-
quential enzymatic digests with trypsin and deoxyribo-
nuclease I (DNase I) (Invitrogen, Carlsbad, CA, USA).
After each enzymatic digestion, cell suspensions were
filtered through a 100 μm cell strainer and finally, the
cells were collected by centrifugation for five minutes at
200 × g. In order to expand MSCs, the cell pellets were
suspended and cultured at 37°C in a 5% CO2/95% air at-
mosphere in (Dulbecco’s) modified Eagle’s medium ((D)
MEM) supplemented with 20% foetal calf serum (FCS),
2% penicillin/streptomycin, 1% L-glutamine and 2% Fun-
gizone Amphotericin (Gibco, Grand Island, NY, USA).
Cells grew as fibroblastic cells that developed into visible
colonies after seven days of culture and after twenty days
reached 90% confluence. At this time, we recovered
the cells using a trypsin- ethylenediaminetetraacetic acid
(EDTA) solution for culture expansion and we expanded
the cells until 29 population doublings (pd, corresponding
to passage 20 and calculated as described below). Every 6
pd (corresponding to 4 passages) PD-MSCs were charac-
terised for cell growth, phenotypic profiles and gene ex-
pression up to 29 pd.
Cell growth
For the cell growth curve, cells were seeded in six-well
culture plates at a density of 5 × 104 cells/well, cultured
at 37°C and 5% CO2, and viable cells were counted (try-
pan blue dye exclusion test) every day from day 1 to day
12 of culture. The pd of cultured PD-MSCs and adher-
ent PD neurospheres expanded was calculated at every
passage according to the equations log10 (the number of
harvested cells/the number of seeded cells) and log2 (the
number of harvested cells/the number of seeded cells),
respectively. The finite pd were determined by cumula-
tive addition of total numbers generated from each pas-
sage considered.
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Cultured cells were harvested and the expression of cell
surface markers was analysed by direct or indirect im-
munofluorescence using a FACSCalibur cytofluorime-
ter (Becton Dickinson, Sunnyvale, CA, USA). For direct
immunofluorescence, the PD cells were incubated with
fluorescein isothiocyanate (FITC)-conjugated antibodies
against human highly polymorphic class I leukocyte an-
tigens (HLA-ABC) (Becton Dickinson); human class II
leukocyte antigen (HLA-DR) of the major histocompatibility
complex (MCH) (BD-Pharmingen, San Diego, CA, USA);
different cluster of differentiation (CD), such as CD44 mol-
ecule Indian blood group (CD44) (Miltenyi Biotec, Calderara
di Reno, Italy) or Thy-1 cell surface antigen (CD90) (Miltenyi
Biotec); or with phycoerythrin (PE)-conjugated antibodies
against protein tyrosine phosphatase, receptor type C
(CD45) (Miltenyi Biotec), CD133 (Miltenyi Biotec) and
endoglin (CD105) (Miltenyi Biotec) for one hour on ice and
immediately analysed by flow cytometry (FCM). For
indirect immunofluorescence, cells were incubated with
the primary antibodies 5'-nucleotidase, ecto (CD73)
(Santa Cruz Biotechnology, San Diego, CA, USA), integ-
rin beta 1 fibronectin receptor, beta polypeptide, antigen
(CD 29) (Stemgent, San Diego, CA, USA), stage-specific
embryonic antigen-4 (SSEA-4) (Santa Cruz Biotechnol-
ogy), UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase,
polypeptide 5 (SSEA-3) (Santa Cruz Biotechnology) or
octamer-binding transcription factor 4 (Oct-3/4) (Santa
Cruz Biotechnology) for one hour on ice and then incu-
bated with a secondary FITC-conjugated antibody for 50 mi-
nutes on ice and immediately analysed by FCM.
Induced pluripotent stem (iPS) cells
Lentiviral vectors employed for the induction of repro-
gramming harbored bicistronic plasmids expressing Oct-
3/4 and either Sox2 or Klf4 (OSK). The original vector
was kindly provided by Prof. Luigi Naldini (Fondazione
San Raffaele, Milan, Italy). Low passage 293 T cells (Cell
Biolabs, San Diego, CA, USA) were used to produce len-
tiviruses expressing each pair of transgenes, using the
pPAX2 and pVSV-G packaging constructs and a calcium
phosphate transfection protocol. Supernatants containing
OSK lentiviruses were collected 48 hours later, filtered
and used freshly right after preparation. To generate iPS,
human adult skin fibroblasts were exposed to a mixture of
equal volumes of the two OSK lentiviral vectors. Four days
after transduction, cells were trypsinised and plated
on a mouse MEF-feeder layer (Millipore, Billerica, MA,
USA) and cultured in propagation medium composed of
knock-out (D)MEM containing 20% knock-out serum re-
placement, L-glutamine, non-essential amino acids, basic
fibroblast growth factor (bFGF), B27, N2 supplement, β-
mercaptoethanol, penicillin (100 U/ml) and streptomycin
(100 mg/ml). Expression of embryonic genes was analysedby qRT-PCR. Total RNA was extracted from cells using
Trizol (Invitrogen). A quantity of 1 μg of total RNA was
reverse transcribed to cDNA using SuperScript III Kit
(Invitrogen) to be amplified by qRT-PCR. Sybr Green PCR
master mix (Applied Biosystems, Barlington, ON, Canada)
and primers specific for markers of pluripotency were
used. Samples were analysed in triplicate using the Tetrad
2 (Biorad, Richmond, CA, USA) and 7900HT qRT-PCR
(Applied Biosystems). Immunofluorescence staining was
performed on cells cultured on petri dishes, fixed in 4%
paraformaldehyde and permeabilised with 0.5% Tween 20.
The cells were then incubated with the primary anti-
bodies, such as Oct-3/4 (Abcam, San Francisco, CA,
USA), Nanog (Abcam), SSEA4 (Stemgent). To verify te-
ratoma formation, 5 × 105 human iPS cells were injected
subcutaneously in five NODscid mice. Tumours were
sought after four weeks. iPS cells were used as control
cells for the analysis of stemness genes.Western blot analysis
Samples were solubilised in urea buffer on ice. Protein
content in the different samples was quantified by using
the Bradford method (Bio-Rad). Aliquots (25 μg) of pro-
teins were subjected to 10% sodium dodecyl sulphate-
polyacrylamide gel electrophoresis (SDS-PAGE) and the
resolved proteins were blotted on a nitrocellulose mem-
brane, which was then blocked in TBS buffer (20 mM
tris Base, 137 mM NaCl, 1 M hydrochloric acid, pH 7.6)
containing 5% nonfat dry milk (Bio-Rad) for at least one
hour. Blots were then incubated with the primary anti-
bodies anti-Oct-3/4 (Becton Dickinson) and anti-β-actin
(Sigma, San Louis, MO, USA). Peroxidase-labelled anti-
mouse immunoglobulin G (IgG) (Sigma) was used as
secondary antibody. Immunoblots were processed for
enhanced chemiluminescence detection (Amersham Life
Sciences, Little Chalfont, Buckinghamshire, UK). The
relative amount of transferred proteins in a given sample
was quantified by scanning X-ray films and by densitom-
etry analysis (Total Lab image analysis solution, version
2003, Nonlinear Dynamics, Newcastel upon Tyne, UK).Total RNA preparation
Total RNA was isolated from each sample of uncultured
placenta, PD-MSCs, secondary PD-neurospheres and ex-
panded PD-neurospheres using a Total RNA Purification
Kit (Norgen Biotek Corporation, Thorold, CA, USA)
according to the manufacturer’s instructions. The RNA
quantity was determined by absorbance at 260 nm using
a NanoDrop UV–VIS spectrophotometer. The quality of
each sample was checked with an Agilent BioAnalyzer
2100 (Agilent RNA 6000 Nanokit). Samples with an RNA
integrity number (RIN) lower than 8.0 were discarded.
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(RT-PCR) analysis
RNA (500 ng) was retro-transcribed according to stand-
ard conditions and the cDNA was then subjected to real
time PCR analysis with an Applied Biosystems 7900HT
thermal cycler, using the SensiMixSYBR Kit (Bioline,
London, UK) and the following specific primers: nanog
homeobox, hNANOG (sense (s): AGATGCCTCACAC
GGAGACT, antisense (as): TTTGCGACACTCTTCTC
TGC); prominin 1, hPROM1 (s: TCCACAGAAATTTA
CCTACATTGG, as: CAGCAGAGAGCAGATGACCA);
SRY sex determining region Y-box 2, hSOX2 (s: TGCT
GCCTCTTTAAGACTAGGAC, as: CCTGGGGCTCAA
ACTTCTCT); SRY sex determining region Y-box 9,
hSOX9 (s: GTACCCGCACTTGCACAAC, as: TCGCTC
TCGTTCAGAAGTCTC); POU class 5 homeobox 1,
hPOU5F (s: CTTTGAGGCTCTGCAGCTTAG, as: GG
TTTCTGCTTTGCATATCTCC); polycomb ring finger
oncogene, hBMI1 (s: TTCTTTGACCAGAACAGATT
GG, as: GCATCACAGTCATTGCTGCT); ATP-binding
cassette, sub-family G (WHITE), member 2, hABCG2 (s:
TGGCTTAGACTCAAGCACAGC, as: TCGTCCCTGC
TTAGACATCC); cyclin A2, hCCNA2 (s: GGTACTG
AAGTCCGGGAACC as: GAAGATCCTTAAGGGGTG
CAA); cell e-box transactivator 2, hNEUROD1 (s: CTGC
TCAGGACCTACTAACAACAA, as: GTCCAGCTTGG
AGGACCTT); nestin, hNES (s: TGCGGGCTACTGAA
AAGTTC, as: TGTAGGCCCTGTTTCTCCTG); vimen-
tin, hVIM (s: GTTTCCCCTAAACCGCTAGG, as: AGC
GAGAGTGGCAGAGGA); myelocytomatosis viral rela-
ted oncogene neuroblastoma derived, hMYCN (s: CCAC
AAGGCCCTCAGTACC, as: TCCTCTTCATCATCTTC
ATCATCT); v-kit Hardy-Zuckerman 4 feline sarcoma
viral oncogene homolog, hKIT (s: CGTGGAAAAGAGA
AAACAGTCA, as: CACCGTGATGCCAGCTATTA);
ectonucleotide pyrophosphatase/phosphodiesterase 2,
hENPP2 (s: GCACATCGAATTAAGAGAGCAG, as:
GGGGGAGTCTGATAGCACTG); glutamate receptor
ionotropic AMPA3, hGRIA3 (s: CCTCTATGACACAGA
ACGAGGA, as: TGCACTGCTGCTTCCATAAT); TATA
box binding protein, hTBP (s: GAACATCATGGATCAG
AACAACA, as: ATAGGGATTCCGGGAGTCAT); gly-
ceraldehyde-3-phosphate dehydrogenase, hGAPDH (s:
AGCCACATCGCTCAGACA, as: GCCCAATACGAC
CAAATCC); protein phosphatase 1, hPPIA (s: ATGCTG
GACCCAACACAAAT, as: TCTTTCACTTTGCCAAA
CACC); CDKN2A, hCDKN2A (s: TGCCTTTTCACTGT
GTTGGA, as: TGCTTGTCATGAAGTCGACAG).
Conversion of PD-MSCs into spheres neural cells
PD-MSCs from 6 pd (corresponding to passage 4) were
plated in nonadherent conditions: serum-free neurobasal
medium (Gibco), supplemented with 20 ng/ml epidermal
growth factor (EGF) (Sigma), 40 ng/ml bFGF (Sigma) and1% neuronal supplements N2 (Gibco) and B27 (Gibco),
and 2 μg/ml heparin using 60 mm low-attachment
culture dishes at a density of 1.9 × 106 cells/dish. After
four days from seeding, the cells formed primary floating
neurosphere-like structures. These structures grew rapidly
until day 7. At this time, before the obtained neurosphere-
like structures became necrotic, we harvested them and
resuspended them in Accutase enzymatic solution (Gibco)
for five minutes at 37°C and then mechanically dissociated
them into a single cell suspension. The cells were re-
seeded in the same non-adherent conditions as above, and
the secondary spheres were allowed to form. This protocol
was applied for more rounds of spheres formation. As
positive or negative controls we used NB LAN-5 (kindly
provided by Dr. Doriana Fruci) and SK-N-SH (purchased
from American Type Culture Collection, Manassas, VA,
USA) cell lines, respectively.
Characterisation of secondary neurosphere
Secondary PD-neurospheres were dissociated as previ-
ously described. Cells were incubated with the primary
antibodies directed against proliferation-related Ki67
antigen (BD-Pharmingen, Franklin Lake, NJ, USA), nestin
(Santa Cruz Biotechnology), vimentin (Sigma), CD133
(Miltenyi Biotec), cleaved Notch1 (Cell Signaling, Boston,
MA, USA) for one hour on ice and then with a secondary
FITC-conjugated antibody for fifty minutes on ice and im-
mediately analysed by FCM.
Differentiation assays
For neuronal differentiation, adherent PD-neurospheres
were seeded in (D)MEM supplemented with 20% FCS,
2% penicillin/streptomycin, 1% L-glutamine and 2% Fun-
gizone Amphotericin. After 24 hours they were treated
with 10 μM retinoic acid (RA) (Sigma). For morpholo-
gical analysis cells were seeded in 100 mm dishes (Becton
Dickinson) at a density of 2 × 105 cells and after three days
of RA treatment the cells were viewed with an inverted
phase contrast microscope at 40X magnification. The cells
were scored as differentiated if the length of the neurite
extensions was at least two times the diameter of the cell
body. Tracing of the individual neurites and branch points
was evaluated based on the cells bearing neurites as deter-
mined from the cell culture images. A total of >300 cells
was examined in five randomly chosen fields in each
treated and untreated sample. The projection images were
semiautomatically traced with NIH ImageJ using the Neu-
ronJ plugin and the total dendritic length of each individ-
ual neuron was analysed.
For immunofluorescence assays cells were seeded onto
multi-chamber slides (Becton Dickinson) at a density of
1 × 104 cells. After one, three and seven days of treat-
ment, the slides were washed in phosphate-buffered sa-
line (PBS) 1X with calcium and magnesium, fixed in
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in Tris buffered saline (TBS) 0.05 M pH 7.4 with 1% Tri-
ton X-100 for 15 minutes. After blocking in TBS 10%
serum for 30 minutes, slides were incubated with anti-
glial fibrillary acidic protein (GFAP) (Dako, Glostrup,
Denmark) antibody overnight at 4°C. After washing in TBS,
they were incubated with goat anti-rabbit Alexa Fluor 488
antibody (Invitrogen) for 30 minutes and finally washed
twice in TBS. For other labelling, slides were permeabi-
lised with triton 0.1% for eight minutes, washed twice
in PBS 1X and incubated with anti-neurofilament 200
(NF200) (Sigma) antibody, neuronal nuclei (NeuN)
(Chemicon, Millipore, Milan, Italy) and βIII tubulin
(Santa Cruz) antibodies for one hour. After three washes
in PBS 1X, the slides were incubated with goat anti-mouse
Alexa Fluor 594 (Invitrogen) or with goat anti-rabbit Alexa
Fluor 488 (Invitrogen) antibodies for 30 minutes. Nuclei
were counterstained with Hoechst 33342 (Sigma) 1 μg/ml
for 10 minutes. Images were acquired with an Olympus
BX51 fluorescence microscope and analysed with I.A.S.
software (Delta Sistemi, Legnano, Italy). The brightness
and contrast of the acquired images were adjusted, and
the figures were generated using Adobe Photoshop 7.0.
Negative controls, that is, cells not treated with RA, were
also included.
For the membrane potential measurement, cells were
seeded in 100 mm (Becton Dickinson) at a density of 2 × 105
cells and after one, three and seven days of RA treatment
were analysed by FCM using the membrane-potential-
sensitive dye 3,3’-dipentyloxacarbocyanine iodide (DiOC5).
DiOC5 was added to the cell suspensions at a final
concentration of 50 nM. Valinomycin (Sigma) (final con-
centration 5 μM) treated samples were used as hyperpo-
larised controls.
Cell cycle analysis
The cell cycle was evaluated using propidium iodide (PI)
(MP Biomedicals, Solon, OH, USA) staining and FCM
analysis. Adherent PD-neurospheres were harvested,
fixed in 70% ethanol for at least one hour and stained
with a solution containing 50 μg/ml PI and 75 KU/ml
ribonuclease (RNase) (Sigma) in PBS 1X for 30 minutes
at room temperature. Twenty thousand events per sam-
ple were acquired. The percentages of the cell cycle dis-
tribution were estimated on linear PI histograms by
using the MODFIT software.
BrdU incorporation
Adherent PD-neurospheres were seeded onto multi-
chamber slides at a density of 2 × 104 cells and were cul-
tured for 24 hours, and then 10 μM bromodeoxyuridine
(BrdU) was added to the medium for 30 minutes. Cells
were fixed in a solution of acetone and methanol (1:1)
for 15 minutes at −20°C. Cells were rinsed with PBS 1Xfor 10 minutes and incubated with 3 N chloridic acid
(HCL) for 20 minutes. Cells were washed twice with
borax-borate buffer (pH 9.1) to neutralise the acidic pH
and three times with PBS 1X. The samples were in-
cubated with monoclonal antibody anti-BrdU (Roche,
Mannhem, Germany) in complete medium containing
0.5% Tween-20 at 4°C for one hour. After being washed
twice in PBS 1X, cells were exposed to FITC-conjugated
F(Ab’)2 anti-mouse (Dako) in PBS at 4°C for 30 minutes.
Finally, the cells were washed twice with PBS 1X and
nuclei were then counterstained with Hoechst 33342
(Sigma), 1 μg/ml for five minutes. Immunofluorescence
was carried out using an inverted fluorescence micro-
scope (Leica Microsystems GmbH, Wetzel, Germany).
Images were acquired using Canon Remote Capture
software and enhanced with Adobe Photoshop CS. As a
positive control, we used the NB cell line LAN-5; we
also used negative controls without the antibody.
Colony-forming assay
Adherent PD-neurospheres were seeded at clonal dens-
ity (1.5 × 103 cells) in a 60-mm dish. Fifteen days after
seeding, the cells were fixed for one hour with a solution
of 1% Coomassie Blue R250 (Bio-Rad, Hercules, CA,
USA) in ethanol. The dishes were then washed with
ddH2O, and the colonies (at least 50 cells) were counted.
The results were expressed as plating efficiency (percent-
age of colonies formed out of cells seeded). LAN-5 and
SH-SY5Y cells (purchased from American Type Culture
Collection) were used as controls.
FCM ploidy measurement
Ploidy was measured using normal human lymphocytes
as internal standard and expressed as DNA index (DI),
which represents the ratio of relative G0/G1 DNA con-
tent versus normal diploid lymphocyte. Thus, a DI value
of 1.0 is synonymous with a normal diploid DNA con-
tent. The cells were processed as described above for cell
cycle analysis. The standard sample (lymphocytes) was
prepared as a single sample or mixed with the unknown
samples at a concentration of 1:2. NB LAN-5 cells were
used as control for aneuploid tumour cells. A total of at
least 30,000 cells was measured at a flow rate of less
than 200 cells/second to minimise coincidences of fluor-
escence signals. The coefficient of variation of the G0/G1
peak of the samples measured ranged from 0.9% to 5.0%,
for a mean of 3.0%.
Cytological analysis
The cytology of the adherent PD-neurospheres expanded
was studied by Papanicolau staining after 41 pd in cul-
ture. Uncultured PD-neurospheres and LAN-5 NB cells
were used as normal or tumour control, respectively.
Amendola et al. Stem Cell Research & Therapy 2014, 5:55 Page 6 of 18
http://stemcellres.com/content/5/2/55Analysis of the neuroblastoma GD2 and N-Myc markers
Adherent PD-neurospheres expanded in vitro for differ-
ent passages were analysed by indirect immunofluores-
cence. Cells were incubated with the antibody GD2
(Abcam, Cambridge, UK) and with N-Myc (Santa Cruz)
for one hour on ice and then with a FITC-conjugated
antibody for 50 minutes on ice and immediately ana-
lysed by FCM. LAN-5 NB cells were used as a positive
control.Figure 1 MSCs obtained from human amniotic and chorionic membra
derived from three different placentas (P2, P10, P26) at different days from
light microscope images of P2, P10 and P26 placenta adherent cells subcu
6 pd (passage 4). Original magnification: 40X. C) FCM analysis of HLA-ABC a
negative sample was incubated with the corresponding isotype. The cytog
similar results. FCM, flow cytometry; MSCs, mesenchymal stem cells; pd, poIn vivo experiments
NOD.CB17-Prkdcscid/NCrHsd male 5-week-old mice
were purchased from Harlan Laboratories (San Pietro al
Natisone (UD), Italy). Six mice were injected subcuta-
neously in the flanks with adherent PD-neurospheres
transformed and expanded for 41 pd, corresponding to
19 passages (106 cells/mouse in 200 μl of Matrigel; BD
Biosciences- Discovery Labware). Mice were inspected
weekly for the presence of tumour up to five monthsnes of term placentas. A) Inverted light microscope images of cells
adhesion on culture plastics. Original magnification: 40X. B) Inverted
ltured in vitro. The micrograph is an example of a five-day culture at
nd HLA-DR antigens in P2, P10 and P26 placenta cultured cells. A
rams shown are representative of three different experiments with
pulation doubling.
Figure 2 (See legend on next page.)
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Figure 2 Characterisation of PD-MSCs. A) In vitro growth curve of the PD-MSCs derived from P2, P10 and P26 placentas at 6 pd. B) FCM
analysis of cell surface markers in five-day culture at 6 pd. A negative sample was incubated with the corresponding isotype. The cytograms
relative to P2, P10 and P26 placentas are representative of three different experiments with similar results. C) Levels of the indicated mRNA in
PD-MSCs from P2 (dark grey), P10 (black) and P26 (light grey) after five days of culture at 6 pd. The data are reported as the level of mRNA relative
to the uncultured placenta and are the means + SD (n = 3). Statistical significance: **P <0.01; ***P <0.001. D) Levels of Oct-3/4 protein in PD-MSCs
relative to P2, P10 and P26 placentas compared to iPS. Each lane was loaded with 25 μg proteins from cell lysates and β-actin was used as the
control for loading equal amounts of proteins. The experiment was repeated three times showing similar results. Band intensities were measured
by densitometry. FCM, flow cytometry; iPS, induced pluripotent stem cells; PD-MSCs, placenta-derived mesenchymal stem cells; pd, population
doubling; SD, standard deviation.
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were fixed in 4% formalin overnight and processed
through an ethanolic dehydration series for paraffin em-
bedding. Five micrometer paraffin sections were cut for
haematoxylin and eosin staining.
To assess reactivity for human HLA-ABC antigen,
immunohistochemistry was performed using a human
monoclonal antibody anti-HLA class 1 ABC (Clone
ab70328 Abcam, Cambridge, UK) according to the
standard streptavidin-biotin peroxidase complex
method. The reaction was developed by adding a
diaminobenzidine-tetrahydrochloride (DAB) chromogen
mixture. After haematoxylin counterstaining, slides were
permanently mounted and analysed for the presence and
distribution of the immunostaining.
Statistical analysis
The data are expressed as mean values ± standard devi-
ation (SD). Statistical significance of differences between
groups was tested by paired Student’s t-test or, if there
were more than two groups, by one-way analysis of vari-
ance (ANOVA).
Results
Isolation and characterisation of PD-MSCs
We isolated and analysed cells obtained from amnion
and chorion full-term placental membranes. A selection
was performed using the classic adhesion method on
culture plastic. The protocol was successful in 30 of the
35 placentas collected. We show the results relative to
three representative placentas.
PD-MSCs showed plastic adherence and a typical
fibroblastic-like morphology using light microscopy and
developed visible colonies after seven days in 5% CO2
at 37°C. These colonies, in turn, started to proliferate
steadily; the flasks were almost 60% to 70% confluent at
day 14, and after 20 days in culture, the cell monolayer
reached approximately 90% confluence (approximately
1.6 × 106 cells/50 cm2) (Figure 1A). Therefore, the adher-
ent cells readily propagated in vitro after successive cy-
cles of trypsinisation; moreover, they formed subcultures
that maintained the same fibroblast-like morphology and
saturation density of those obtained after 20 days of
culture (Figure 1B). The immunological properties of thePD-MSCs were analysed after 6 pd (corresponding to
passage 4) of subculturing using FCM. These derived
cells were strongly positive for the highly polymorphic
HLA class I antigens (HLA-A, HLA-B, HLA-C), and
they were negative for MCH class II (HLA-DR), de-
cisively identifying their foetal origin (Figure 1C).
Cells duplicated exponentially until day 7, when
they reached a plateau phase; the mean doubling time
of the exponential cell population was about 36 hours
(Figure 2A). The percentage of cell viability was high
(median value 93%, range 86% to 95%) (data not shown).
The cell-surface phenotypes were characterised using
FCM (Figure 2B). PD-MSCs were positive for MSC mar-
kers, such as CD44, CD73, CD90, CD29, and CD105, and
for the stage-specific embryonic antigens SSEA-4, and
they were negative for SSEA-3 and Oct -3/4. The haem-
atopoietic marker CD45 and the antigen CD133 were not
expressed.
On the other hand, PD-MSCs showed an increase in
the expression of genes related to embryonic stem cell
phenotypes, including POU5f (about 3-fold) and NANOG
(with a maximum value of about 6-fold), of the CD133 en-
coding gene PROM1 (with a maximum value of about 14-
fold) and of the other two stemness-related genes, SOX2
(with a maximum value of about 8-fold) and BMI1 (about
4-fold), compared with non-cultured placentas (Figure 2C).
To really demonstrate that PD-MSCs have a stemness sig-
nature we compared the expression of the main stemness-
related genes (POU5f, NANOG and SOX2) in these cells
with those in iPS cells used as positive control. The Δct
values of the indicated genes in iPS cells, uncultured pla-
centa and in three different cultured placentas evaluated
by real time PCR are shown in Additional file 1: Figure S1.
Δct values, calculated by the Δct method after normalising
real time RT-PCR Ct on the average of the endogenous
controls, are inversely correlated with the amount of the
gene present in the sample. It is evident that the expres-
sion of the three genes appears upregulated in iPS cells
and in PD-MSCs with respect to uncultured placenta,
thus further demonstrating that the PD-MSCs have fea-
tures of embryonic stem cells.
Considering the key role of the stemness-related fac-
tors, such as Oct-3/4 SSEA-3 and CD133, and not ha-
ving a clear demonstration of their expression by FCM
Figure 3 (See legend on next page.)
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Figure 3 Neural lineage induction and terminal differentiation. A) Secondary PD-neurospheres after four and seven days of culture in the
non-adhesion conditions. LAN-5 and SK-N-SH NB cells were used as positive and negative controls, respectively. B) FCM analysis of the cell cycle
related marker Ki67 in secondary PD-neurospheres after seven days of culture. The negative is the sample incubated with the corresponding
isotype. The cytograms shown are representative of three different experiments with similar results. C) FCM analysis of the indicated neural stem
cells markers in secondary PD-neurospheres after seven days of culture. The negative is the sample incubated with the correspondent isotype.
The cytograms shown are representative of three different experiments with similar results. D) Levels of the indicated mRNA in secondary
PD-neurospheres (black) after seven days of culture. The data are reported as the level of mRNA relative to the PD-MSCs (white) after five days of
culture at 3.6 pd (passage 4) and are the means + SD (n = 3). Statistical significance: *P <0.05; **P <0.01; ***P <0.001. FCM, flow cytometry; PD-
MSCs, placenta derived-mesenchymal stem cells; pd, population doubling; SD, standard deviation.
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We found the presence of Oct-3/4 in all three cultured
placentas (Figure 2D), while for SSEA-3 and CD133 ex-
pression, the western blotting confirmed the absence of
these molecules in PD-MSCs (data not shown).
The PD-MSCs displayed no visible changes in terms
of their morphology, cell proliferation, phenotypic pat-
terns or gene expression profiles at up to 29 pd (data
not shown).
PD-MSCs acquire a neuronal differentiated phenotype
Because it has been reported that amnion and chorion
cells acquire an ectodermal-lineage phenotype in vitro
and, in particular, are able to differentiate into neurons
[18], we induced PD-MSCs into the neural lineage by
sphere-forming assay using placenta P10. After four
days, PD-MSCs formed primary floating neurosphere-like
structures (data not shown). Secondary neurospheres were
obtained after the disaggregation of primary neurosphere-
like structures into single cells and subsequent culture
under identical culture conditions. After seven days, the
newly formed spheres grew rapidly in size, whereas non-
proliferating cells died (Figure 3A). For a positive control,
we used the LAN-5 NB cell line, which is known to form
spheres in non-adherent culture conditions. To confirm
that the increase in colony size was due to the proli-
feration, we performed Ki67 immunostaining on sec-
ondary dissociated spheres at day 7. We found that
approximately 30% of the secondary PD-neurospheres
population showed positive antigen expression, indicating
that these spheres derive from cycling cells and not by re-
aggregation of the dissociated cells (Figure 3B). As a con-
trol, we used neurospheres derived from the LAN-5 NB
cell line. We then characterised the PD secondary neuro-
spheres for the expression of some neural lineage-related
markers. The spheres showed approximately 48% Notch
1, 35% nestin, 99% vimentin and 20% CD133 FCM posi-
tivity (Figure 3C). The gene expression profile of the PD
secondary neurospheres showed that the NES, VIM and
NEUROD1 genes were up-regulated compared with their
levels in PD-MSCs, whereas PROM1 remained at an
expression level similar to that in the PD-MSCs. The
stemness-related genes SOX2, SOX9 and BMI1 were up-
regulated as well, confirming the stem cell-like features ofthese neurospheres. By contrast, the expression of embry-
onic stem cell-related genes (POU5f and NANOG) did not
significantly change when compared with PD-MSCs.
Moreover, we also found a significant decrease of the ex-
pression of the gene encoding for cyclin A (CCNA2),
which is involved in the control of S phase progression.
These data are consistent with the increase of the cell-
cycle cdks inhibitor gene CDKN2A encoding for p16INK4
(Figure 3D).
To verify the ability of the PD-neurospheres to dif-
ferentiate into neurons, we subcultured the dissociated
spheres in a medium containing serum and we in-
vestigated the morphological and functional changes that
occurred in adherent PD-neurospheres after RA. In
Figure 4A we show light micrographs of cells grown
with or without RA indicating that untreated cells had a
fibroblast-like morphology; but upon exposure to RA,
the cells changed to a neuron-like shape with clear evi-
dence of the presence of peripheral projection from the
cell body strongly remindful of neurites outgrowth. The
number of cells with neurites increased approximately
90% after RA treatment. As shown in Figure 4B the
neurite length evaluated in RA treated cells had a me-
dian value of 453 μm (range = 261 to 1067) compared to
untreated cells with a median value of 282 μm (range =
190 to 436). Moreover, the expression of early- or late-
stage neuron markers such as βIII-tubulin, neurofila-
ment 200 (NF200) and neuronal nuclei (NeuN) after
RA exposure demonstrated the ability of such cells to
terminally differentiate into neurons. On the other
hand, the same differentiation protocol did not reveal
the presence of GFAP-positive astrocytes (Figure 4C).
In order to evaluate whether differentiated adherent
PD-neurospheres showed a neuron function, we mea-
sured membrane hyperpolarization which is typical of
differentiated neurons by using the fluorescent mem-
brane potential probe DiOC5. As shown in Figure 4D
we found a hyperpolarization of the plasmatic mem-
brane in RA treated cells evident already at day 1.
The hyperpolarization found in these cells was com-
parable to that obtained in valinomycin treated cells
used as positive control.
Similar results were obtained also using P2 and P26
(data not shown).
Figure 4 (See legend on next page.)
Amendola et al. Stem Cell Research & Therapy 2014, 5:55 Page 11 of 18
http://stemcellres.com/content/5/2/55
(See figure on previous page.)
Figure 4 Adherent PD-neurospheres differentiate upon RA. A) Inverted light microscopic images of adherent PD-neurospheres (NT) or
RA-treated for three days. Original magnification: 40X. The images shown are representative of three different experiments with similar results.
B) Neurites length (μm) analysis. Distribution of the neurite outgrowth length as measured in adherent PD-neurospheres treated with RA for three
days. Statistical significance: ***P ≤0.001. C) Representative fluorescent images of PD-neurospheres expanded for 12 passages and exposed to RA
for one, three and seven days. Red = NF200 and βIII tubulin, Green = GFAP and NeuN immunostaining and blue = HOECHST. Scale bar: 10 microns.
D) Distribution of intracellular DiOC5 fluorescence in adherent PD-neurospheres treated or not with RA for one, three and seven days expressed
as % increase of treated cells versus untreated (black). Valinomycin treated cells (white) were used as hyperpolarised control. The result shown is
representative of three different experiments overlapping. GFAP, glial fibrillary acidic protein; PD, placenta-derived; RA, retinoic acid.
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PD-neurospheres were expanded as adherent cultures
for several population doublings. At 3.6 pd these cells
already showed an increase in the percentage of S-phase
cells (%S = 25) compared with uncultured neurospheres
(%S = 2). We monitored cell proliferation at different
population doublings; at 41 pd, the percentage of S
phase cells was maintained at high levels (%S = 36). As a
control, we used the in vitro established LAN-5 NB cell
line (Figure 5A). To confirm the proliferation activity,
we measured BrdU incorporation into adherent PD-
neurospheres in both unexpanded cells (1 pd) and after
41 population doublings (41 pd). A strong BrdU in-
corporation was evident at 41 pd compared with un-
expanded neurospheres, confirming that the expanded
neurospheres maintained a proliferative potential in vitro.
LAN-5 NB cell BrdU incorporation was used as a control
(Figure 5B).
The colony formation assay also demonstrated that
these cells retained proliferative potential after in vitro
expansion. Plating efficiency, evaluated in the adherent
PD-neurospheres after 15 days of in vitro culture, was
increased by approximately five-fold during the expan-
sion, achieving values comparable to those observed in
established NB cell lines, such as LAN-5 and SH-SY5Y
(Figure 5C). In addition, calculation of the mean doub-
ling time of the adherent PD-neurospheres expanded
cell population was 26 hours (data not shown). These re-
sults further demonstrate the transforming capacity of
these cells.
The ability of adherent PD-neurospheres to transform
during their in vitro expansion was also demonstrated
by analysing the expression of some related genes using
qRT-PCR. Figure 5D shows that changes in gene expres-
sion levels were related to stemness, proliferation and
tumour transformation. Interestingly, the expression of
the gene CCNA2 was increased by approximately 40-
fold and CDKN2A was decreased by approximately 90-
fold, confirming the substantial increase in proliferative
potential that is a characteristic of transformed cells.
Moreover, the expression levels of genes that are related
to a more aggressive phenotype in NB cells (for example,
ENPP2, GRIA3) were increased by approximately two-
fold. Furthermore, we found increased expression levelsof the MYCN gene (approximately 1.5-fold), which is a
hallmark of NB.
Interestingly, cytogenetic analysis using the Array-
Based Comparative Genomic Hybridization (aCGH) as-
say did not reveal any pathogenetic alteration (data not
shown).
Since abnormal ploidy is a cellular feature frequently
associated with solid tumours we studied the DNA con-
tent by FCM. Flow cytometric DNA content measure-
ment of adherent PD-neurospheres unexpanded (1 pd)
displayed a diploid DNA content (DI = 1.0) indistin-
guishable from normal lymphocytes. By contrast, ad-
herent PD-neurospheres transformed in vitro for 41 pd
showed an abnormal hyperdiploid DNA content with a
DI value of 1.3. The LAN-5 cells have a DI value of 1.3
(Figure 6A). The cytological analysis of the same sam-
ples demonstrated the presence of multinucleated ab-
normal cells with large prominent nucleoli and increased
nucleo/cytoplasm ratio in PD-neurospheres transformed
(41 pd); whereas the unexpanded adherent neuro-
spheres (1 pd) showed a normal morphology (Figure 6B).
These data further demonstrate that the adherent PD-
neurospheres during the in vitro expansion progress to-
wards a cancer phenotype. The transformation of adherent
PD-neurospheres versus an NB tumour phenotype was
demonstrated by the presence of the NB-specific cell
surface marker, disialoganglioside GD2 and the N-Myc
protein (Figure 6C).
In addition, since the acquisition of mesenchymal mar-
kers could be associated with cancer invasion we also
analysed the expression of mesenchymal markers in the
transformed cells. Our cells maintained the expression
of CD29, CD90, CD73, CD105 and CD44 at a similar ex-
tent to PD-MSCs (see Additional file 2: Figure S2).
To definitely demonstrate the transformation of ad-
herent PD-neurospheres after expansion in vitro, we
evaluated the tumourigenic potential of these cells by
injecting them in NOD.CB17-Prkdcscid/NCrHsd mice.
Even though no visible tumour mass was evident, after
five months mice were sacrificed to perform histological
analysis of the tissues from the injected sites. Histo-
pathological examination demonstrated the presence
in normal muscle tissue of large cells with an infiltra-
tive tumour phenotype showing vesicular nuclei and
Figure 5 (See legend on next page.)
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Figure 5 Propagation and spontaneous transformation of secondary PD-neurospheres. A) Cell cycle FCM analysis in PD-neurospheres
expanded for 3.6 and 41 pd (3 and 19 passages, respectively). The unexpanded secondary PD-neurospheres are also shown (1 pd, 0 passages). As
a control of cell proliferation of an established cancer cell line we used LAN-5 cells. B) Representative fluorescent images of PD-neurospheres
expanded for 41 pd. Green, BrdU immunostaining and blue, HOECHST. Scale bar: 20 microns. C) Left, images of the in vitro colonies obtained in
secondary PD-neurospheres (1 pd) and in PD-neurospheres at different passages of expansion (3.6 and 41 pd) seeded at clonal density and
evaluated after 15 days of culture. Right, plating efficiency values (+SD; n = 5) in the same samples. As positive control we used the LAN-5 and
SH-SY5Y cell lines. Statistical significance: **P <0.01. D) Levels of the indicated mRNA in PD-neurospheres expanded for 41 pd (black). The data are
reported as the level of mRNA relative to the secondary PD-neurospheres (white) and are the means + SD (n = 3). Statistical significance: *P <0.05;
**P <0.01; ***P <0.001. BrdU, bromodeoxyuridine; FCM, flow cytometry; PD, placenta-derived; pd, population doubling; SD, standard deviation.
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(Figure 6D). We confirmed that the engrafted neoplastic
cells in the NOD.CB17-Prkdcscid/NCrHsd mice originated
from a human source using an anti-HLA class 1 ABC
monoclonal antibody by the immunoperoxidase staining
method (Figure 6E).
Similar results were obtained also using P2 and P26
(data not shown).
Discussion
The CSC model links neoplastic cells with normal stem
cell biology. Normal stem cells may be functionally de-
fined as cells with the capacities of self-renewal [19],
multipotency [10] and differentiation [18]. This hierarch-
ical stem cell model is attractive because it provides a
likely explanation for multiple treatment failures and
ideal cellular targets to definitively eradicate refractory
tumours [20]. To date, stem cell–like cells have been
convincingly identified in a number of tumour types, in-
cluding blood, breast, brain, prostate, skin, colon and
lung cancers [4-9]. We suggest the possibility that such
a model may not apply to all solid tumours or may turn
out to be considerably more complex in some cancers.
Regarding NB, whether it results from the CSC model
or from clonal evolution within tumours is still a matter
of intense debate. Recently, Coulon and colleagues [3]
have described an approach to identify and characterise
CSCs in a panel of NB tumours, suggesting that the tu-
mours’ embryonic origin and heterogeneity qualifies NB
tumours as a pertinent model to explore CSC models in
solid tumours. Thus, other authors [11,12] isolated highly
tumourigenic, drug-resistant, sphere-forming cell lines
from NB metastatic bone marrow even though no spe-
cific gene expression profiles have been identified for NB
CSCs, either in primary tumours or in NB cell lines [3].
Moreover, because of their plasticity and the influence of
the environment, it is still unclear to what extent the exist-
ence of an NB-CSC ‘niche’ is dependent on the presence
of the NB-CSCs themselves. Indeed, the phenotypic iden-
tity of the NB-CSCs may shift as the niche changes, and
vice versa, making the identification of NB-CSCs even
more difficult. Thus, the development of stem cell models
to study the molecular mechanisms by which neoplastic
transformation occurs could be useful. The biologicalfeatures and the absence of ethical issues concerning the
use of stem cells isolated from human membranes from
term placentas has allowed us to identify a model to study
spontaneous stem cell transformation. Here, we report
that normal human stem cells from amniotic and chori-
onic placenta membranes are forced into a neural lineage,
expanded in long-term cultures and immortalised by ac-
quiring an NB-like phenotype. Placenta has attracted in-
creasing attention over the past decade as a stem cell
source [21]. Consistent with Bacenkova and colleagues
[22], our data show that amnion and chorion PD stem
cells display plastic adherence and fibroblast-like growth.
Moreover, these PD cells were found to be of foetal origin.
The use of foetal stem cells to study spontaneous trans-
formation, compared with adult stem cells, appears to be
advantageous due to the foetal stem cells’ expansion cap-
acity and accessibility [23]. To assess the stem cell-like
properties of amnion and chorion PD cells, the expression
of stem cell markers and differentiation capacity have
been examined. These cells expressed typical mesen-
chymal markers (CD44, CD73, CD90, CD29, CD105)
but not haematopoietic markers, such as CD45, or neural
progenitor markers, such as CD133 [18], even though we
showed that the CD133 encoding gene PROM1 is ex-
pressed. Moreover, our cells expressed markers associated
with pluripotent (POU5f, NANOG, SOX2 and BMI1) and
multipotent (SSEA-4) human embryonic stem cells, as
also reported by Bacenkova and colleagues [22]. However,
in contrast to these authors, we did not detect the expres-
sion of SSEA-3 protein. This contradictory finding may be
due to the different techniques used to detect this antigen
(we used FCM, whereas they used immunocytochemistry).
On the other hand, Ilancheran and colleagues [18] re-
ported that SSEA-3 expression has yet to be confirmed in
MSCs obtained from foetal membranes.
According to different authors [24-26], we neuralised
MSCs derived from amnion and chorion membranes,
obtaining a model able to acquire neuronal phenotypic
and functional characteristics under specific conditions.
Recent publications present conflicting evidence about
the transformation propensity of human MSCs. Where-
as Gro Vatne Røsland and collaborators [15] observed
spontaneous malignant transformation of bone marrow-
derived adult MSCs in vitro, other investigators have
Figure 6 (See legend on next page.)
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Figure 6 Characterisation of the neoplastic phenotype. A) Frequency histograms of cellular DNA content in PD-neurospheres unexpanded
and expanded for 41 pd. Lymphocytes were used as normal diploid internal standard. LAN-5 NB cells were used as aneuploid DNA content.
Ploidy is expressed as DNA index (DI), which represents the ratio of relative G0/G1 DNA content of sample versus normal diploid lymphocyte. B)
Papanicolau staining of PD-neurospheres unexpanded and expanded for 41 pd. LAN-5 NB cells were used as tumour control. The arrows indicate
multinucleated abnormal cells with large prominent nucleoli. Original magnification: 40X. C) GD2 and N-Myc expression in secondary unexpanded
PD-neurospheres (1 pd) and in PD-neurospheres expanded for different passages (3.6 pd and 41 pd). The negative sample was incubated with
the corresponding isotype. The LAN-5 NB cells were used as a positive control. The cytograms shown are representative of three different experiments
with similar results. D) Spontaneous malignant transformation of adherent PD-neurospheres expanded injected subcutaneously into the flanks of
NOD.CB17-Prkdcscid/NCrHsd mice. Haematoxylin and eosin staining of tissue sections fixed in 4% formalin and paraffin embedding confirmed the
infiltrative tumour phenotype. Original magnification: 40X. a) healthy muscle tissue; b and c) neoplastic nests of cells in muscle tissue. E) HLA-ABC
immunohistochemistry reactivity of tissue sections fixed in 4% formalin and paraffin embedding confirmed the human origin. Original magnification:
40×. NB, neuroblastoma; PD, placenta-derived; pd, population doubling.
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transformation in long-term cultures of both bone mar-
row and adipose tissue-derived human MSCs [27,28]. For
the first time, we show that adherent PD-neurospheres
after long-term in vitro expansion were able to spontan-
eously transform, showing an aneuploid DNA content
even with a CGH assay negative for the presence of patho-
genic copy number variations. It is likely that this technol-
ogy, even with high sensitivity and resolution compared to
conventional GTG-binding, may not be sufficient to de-
tect a low proportion of cells with abnormalities and bal-
anced rearrangements suggesting that changes in the
expression of genes, and not in their amplification, oc-
curred in our cells. These cells were highly proliferative
and formed colonies in vitro with cloning efficiency values
similar to those obtained in NB cell lines. These data are
consistent with an increase in CCNA2 gene expression as-
sociated with a decrease of CDKN2A, indicating that an
alteration of the pathway involved in cell cycle control
may efficiently extend the proliferative lifespan, thus pre-
disposing adherent PD-neurospheres to neoplastic trans-
formation. In agreement with Coulon and colleagues [3],
we found an up-regulation of genes described as CSC
markers, such as PROM1, ABCG2, NES and of genes in-
volved in the reprogramming such as BMI1 [29].
Moreover, we also found an over-expression of MYCN,
ENPP2 and GRIA3 genes previously shown to play a key
role in the development and aggressiveness of the NB
process [30]. Following Rubio et al., we hypothesize
that PD-neurospheres malignant transformation occurred
bypassing senescence by upregulating MYCN and repres-
sing CDKN2A genes. Interestingly, we observed a reduc-
tion of the SOX2 gene expression levels, thus confirming
the neuronal fate. Agreeing with Cohen and collaborators
[31], we found that an upregulation of the KIT gene played
a significant role in NB growth regulation even if its role
in neuronal differentiation is less clear.
Moreover, we demonstrated the transformation of ad-
herent PD-neurospheres after expansion in vitro by in-
jecting them in NOD.CB17-Prkdcscid/NCrHsd mice.
Interestingly, we found the presence of MSC markers inour PD-neurospheres transformed. Our hypothesis is
that, despite the existing difficulty of obtaining tumour
formation after injection of MSCs into mice, the MSC
features could contribute to the uptake of the tumour in
mice.
Conclusions
In this study, we developed a CSC model starting from
normal human stem cells derived from amniotic and
chorionic placenta membranes. We demonstrated that,
under specific differentiation conditions, human amnion
and chorion membrane-derived MSCs can be converted
into neural lineages. In addition, after extensive culture,
in vitro, these cells undergo spontaneous transforma-
tions and acquire an NB-like phenotype.
Additional files
Additional file 1: Figure S1. Expression of the main stemness-related
genes in PD-MSCs compared with iPS positive control. The indicated
mRNA levels were measured, by real time RT-PCR determining Δct values
normalised against the average of the endogenous controls, in iPS
(stacked lines), uncultured placenta (white) and three different cultured
placentas, P2 (grey), P10 (black) and P26 (light grey). Δct values, calculated
by the Δct method after normalizing real time RT-PCR Ct are inversely
correlated with the amount of the gene present in the sample. The
experiment was repeated three times with superimposable results.
Additional file 2: Figure S2. FCM analysis of mesenchymal markers in
adherent PD-neurospheres transformed at 41 pd. Negative is the sample
incubated with the corresponding isotype. The cytograms are representative
of three different experiments with similar results.
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